Recruiting Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia NCT07537738 Conditions Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more Locations Peking University People's Hospital — Beijing, China View Trial Details
Recruiting Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia NCT06001788 Conditions AML, AML With Mutated NPM1, Acute Leukemia, +14 more Locations Banner MD Anderson Cancer Center — Gilbert, Arizona, United States USC Norris Comprehensive Cancer Center — Los Angeles, California, United States UCLA Health - Bowyer Oncology Center — Los Angeles, California, United States UC Irvine Health Chao Family Comprehensive Cancer Center — Orange, California, United States View all 45 locations View more locations Show fewer locations Loading locations... View Trial Details
